Curation SCA10 ATXN10
12 + 2 = 14 / 18
Genetic evidence
Total: 12
Category | Type | Citation | Score | Details |
|---|---|---|---|---|
Singular Evidence | Probands | 6 | Six unrelated SCA10 families were analyzed (three Brazilian, two Mexican mapping families, and one early-onset Mexican patient), comprising 34 SCA10 expansion carriers and 20 relatives with cerebellar ataxia and variable seizures. | |
Collective Evidence | Allele | 1 | An inverse correlation has been observed between the expansion size and the age of onset (r2=0.34, P=0.018). | |
Collective Evidence | Segregation | 1.5 | A four-generation Mexican-American autosomal dominant SCA pedigree showed linkage to chromosome 22q13, with maximum two-point LOD score 4.30 at D22S928 and D22S1161 (θ=0) and informative haplotypes defining recombination events. | |
Statistics | Case-control data | 6 | SCA10 expanded chromosomes shared conserved intragenic/flanking haplotypes; 154 control chromosomes from Brazilian, Mexican, and Portuguese populations were analyzed for haplotype frequencies and showed low-frequency disease-associated flanking haplotypes. |
Experimental evidence
Total: 2
Category | Type | Citation | Score | Details |
|---|---|---|---|---|
Function | Regulatory impact | 1 | pmid:11017075 notes that the large intronic ATTCT expansion could affect ATXN10 transcription or post-transcriptional processing, but preliminary northern blot data showed no obvious SCA10 mRNA change in patient lymphoblastoid cells; pmid:38467784 provides review-level context that STR sequence composition can affect gene expression. | |
Functional Alteration | Patient cells | 1 | Patient lymphoblastoid cells were used for western blotting to exclude expanded polyglutamine proteins and for preliminary northern blot analysis showing no obvious SCA10 mRNA level change; disease-relevant patient-cell functional alteration was not demonstrated. |